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Flow and 
Objectives. This investigation studied the relation between 
regional myocardial blood flow and left ventricular function 
during dobutamine stress in patients with coronary artery dis- 
ease. 
Background. Dobutamine stress is becoming more frequently 
used as an alternative to dynamic exercise in patients with 
ischemic heart disease. 
Methods. We studied 12 patients with coronary artery disease. 
Dobutamine was infused from 5 t~g/kg body weight per min up to 
40 pg/kg per min or until chest pain or other intolerable side 
effects. Regional myocardial blood flow was measured with 
positron emission tomography and oxygen-15-1abeled water. Re- 
gional wall motion was assessed in three short-axis slices by 
magnetic resonance imaging. Each slice was subdivided into four 
regions: septal, anterior, lateral and inferior. A total of 140 
regions were suitable for comparison. 
Results. During stress, new wall motion abnormalities devel- 
oped in 27 regions. Myocardial blood flow (mean -+ SD) increased 
in 113 regions that did not develop wall motion abnormalities 
(0.98 -+ 0.26 [baseline] vs. 1.98 _+ 0.87 [dobutamine] ml/min per g, 
p < 0.001), whereas it did not change significantly in regions with 
stress-induced wall motion abnormalities (1.00 -+ 0.28 [baseline] 
vs. 1.30 "4" 0.62 [dobutamine] ml/min per g, p = NS). An absolute 
decrease in myocardial blood flow below the value at rest was 
observed in seven segments that developed wall motion abnormal- 
ities during stress. 
Conclusions. The normal functional response to dobutamine 
stress is paralleled by an increase in coronary flow, whereas 
mechanical dysfunction is accompanied by a blunted increase, or 
even a paradoxic decrease, in regional coronary flow. 
(J Am CoU Cardiol 1995;26:1187-95) 
Dobutamine stress combined with different imaging tech- 
niques is widely used as an alternative to dynamic exercise in 
patients with ischemic heart disease (1-8). The rationale for its 
use is based on the sympathomimetic properties of dobut- 
amine, which through its inotropic and chronotropic effects, 
increases myocardial oxygen demand (9). In the presence of a 
significant coronary stenosis, myocardial ischemia results from 
the imbalance between increased oxygen demand and limited 
blood supply. However, despite its widespread application, the 
effect of intravenous dobutamine on regional absolute myocar- 
dial blood flow and its relation to wall motion in patients with 
coronary artery disease remains to be elucidated. 
The present study sought o evaluate the effect of dobut- 
amine infusion on absolute myocardial blood flow and left 
ventricular wall motion in patients with documented coronary 
artery disease. Regional myocardial blood flow was measured 
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with oxygen-15-1abeled water and positron emission tomogra- 
phy. We elected to use magnetic resonance imaging (MRI) for 
noninvasivc assessment ofleft ventricular wall motion because 
it offers the best spatial resolution and is less operator depen- 
dent than other available imaging techniques (10). 
Methods  
Patients. Twelve patients (11 men, 1 woman; mean [_+SD] 
age 57 + 9 years, range 38 to 66) with angiographically proven 
coronary artery disease were studied. Five of the patients had 
had a myocardial infarction at least 6 months before the study. 
Exclusion criteria included previous coronary bypass urgery, 
unstable angina, valvular heart disease, atrial fibrillation or 
complete bundle branch block. Women of child-bearing po- 
tential were also excluded, as well as patients with implanted 
pacemakers. All patients underwent coronary and ventricular 
angiography in the 3-month period preceding the study. The 
main clinical, electrocardiographic (ECG) and angiographic 
characteristics of the patients are shown in Table 1. 
Study protocol. All patients underwent, within 2 weeks, on 
different days and in random order, MRI and positron emis- 
sion tomography during dobutamine stress. All studies were 
performed without antianginal therapy: Beta-adrenergic block- 
ing agents were stopped at least 4 days before each examina- 
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Table 1. Baseline Characteristics 
Angiographic Findings 
% Diameter Narrowing 
Pt No./ Age 
Gender (yr)  Angina ECG Findings LAD Cx RCA CC LVEF (%) 
I/M 53 Yes Normal 71 No 64 
2/M 65 Yes Q wave, leads VI-V 2 83 No 59 
3/M 53 Yes Abnormal T waves 66 Yes 50 
4/M 66 Yes Normal 79 No 75 
5/F 48 Yes Normal 78 No 70 
6/M 63 Yes Normal 100 100 Yes 75 
7/M 52 Yes R/S > 1, lead V~ 94 100 Yes 66 
8/M 60 Yes Abnormal T waves 46 66 No 80 
9/M 66 Yes Q wave. leads V~-V, 100 100 Yes 62 
10/M 50 Yes Q wave, leads V~-V~ 100 68 Yes 50 
ll/M 38 No Normal 51 43 49 No 69 
12/M 66 Yes Q wave, lead D 3 48 85 100 Yes 41 
CC presence of collateral circulation; Cx - circumflex coronary artery; ECG - electrocardiographic; F =female; 
LAD = left anterior descending coronary artery; LVEF - left ventricular ejection fraction; M - male; Pt - patient; 
RCA = right coronary' artery. 
tion, calcium antagonists 1 day before and nitrates (except for 
sublingual nitroglycerin) on the same day. Both MRI and 
positron emission tomographic results were analyzed with no 
knowledge of the angiographic data. There were no cardiac 
events (myocardial infarction, pulmonary edema, resuscitation 
or revascularization procedures) between coronary angiogra- 
phy and end of study. 
Dobutamine stress. The same dobutamine infusion protocol 
was used for both MRI and positron emission tomographic 
stress tudies, and in each patient he same maximal dose was 
infused for both MRI and positron emission tomography. 
Dobutamine was infused into an antecubital vein with a pump 
starting at 5 ttg/kg body weight per rain and increasing by 
5/xg/kg per rain every 3 min up to 40 ttg/kg per min or until the 
occurrence of chest pain or other intolerable side effects. Other 
indications for terminating the infusion were significant ar- 
rhythmias, hypertension (systolic pressure ->220 mm Hg) or 
hypotension (decrease > 15 mm Hg relative to the preceding 
stage). One ECG lead was monitored continuously during the 
infusion, and symptoms, heart rate and blood pressure were 
recorded every minute. A 12-lead ECG was recorded every 
2 min during the myocardial f ow study. 
Magnetic resonance imaging. Regional and global left ven- 
tricular function were assessed by MRI using a Picker Inter- 
national HPQ scanner at 1.5 T. Multislice spin echo images 
were acquired in the transaxial plane, followed by cine breath- 
hold images in the vertical ong-axis, horizontal long-axis and 
three short-axis (proximal, middle and apical) planes. The 
imaging technique used was a rapid gradient echo sequence 
with k-space segmentation, such that six to eight phase- 
encoding steps were acquired in rapid sequence, constituting 
one segment. Twenty to 30 interleaved segments were acquired 
to complete a 160 x 256 or 240 x 256 matrix during a single 
period of breath-holding. The echo time of the sequence was 
4.6 ms, and the repetition time was 13 to 16 ms. Eight images 
for each slice through the cardiac ycle were acquired in a very 
short time (from 11 to 16 s). The field of view was 40 cm, and 
slice thickness was 10 mm, with a gap of 5 mm in between the 
slices. The three short-axis lices were chosen in the middle 
portion of the left ventricle, from the vertical long axis, 
excluding the apex, where the end-systolic cavity often disap- 
pears during dobutamine infusion, and the basal part of the 
ventricle, where the aortic root appears during contraction due 
to the descending motion of the heart. The short-axis cine 
images were acquired at rest and during dobutamine infusion, 
with acquisitions at each infusion rate. Due to the increase in 
heart rate during dobutamine infusion, the number of phase- 
encoding steps was reduced so as to acquire the same number 
of images during the cardiac ycle. 
Positron emission tomography. Regional myocardial blood 
flow was assessed using positron emission tomography with 
oxygen-15-1abeled water (H2150) at the Cyclotron Unit (MRC 
Clinical Sciences Centre, Hammersmith Hospital) using an 
ECAT 931-08/12 scanner (CTI/Siemens Inc.), as previously 
described (11). Briefly, an initial transmission scan was per- 
formed using an external source filled with germanium-68 to
allow attenuation correction. To label the blood pool, a 
single-frame, 6-min emission scan was then performed after 
inhalation of oxygen-15 carbon monoxide (3 MBq/ml, 
500 ml/min for 4 min), which binds to red blood cells. 
Thereafter, to measure myocardial blood flow, a 7-rain, 25- 
frame emission scan was recorded after inhalation of 
oxygen-15 carbon dioxide (4 MBq/ml, 500 ml/min for 3.5 min), 
which is rapidly converted to oxygen-15 water by carbonic 
anhydrase in the lung. The same scan was repeated uring 
infusion of the maximal dobutamine dose. 
The study protocol was approved by the Ethics Committee 
of the Royal Brompton and Hammersmith Hospitals. Written 
informed consent was obtained from all patients. Radiation 
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exposure was licensed by the U.K. Administration of Radio- 
active Substances Advisory Committee. 
Data analysis. Analysis of cine MRI. Left ventricular ejec- 
tion fraction was calculated by the biplane area-length method, 
using the end-diastolic and end-systolic frames from the verti- 
cal and horizontal long-axis cine films (12). Regional wall 
motion was analyzed visually by two independent observers, 
and in case of disagreement, the judgment of a third observer 
was binding. Each short-axis plane was subdivided into four 
regions (septal, anterior, lateral and inferior left ventricular 
walls) so that 12 regions were available for comparison i  each 
patient. Each region was scored as normal, hypokinetic, aki- 
netic, or dyskinetic. A test result showing new wall motion 
abnormality or deterioration of at least one category was 
considered positive. 
Analysis of positron emission tomograms. The positron 
emission tomograms were reoriented to short-axis lices to 
correspond to the planes acquired uring MRI. Nine consec- 
utive positron emission tomographic slices of the left ventricle 
were selected, and each slice was 5 mm thick. These slices 
corresponded anatomically to the three 10-mm slices, with a 
gap of 5 mm between slices, obtained by magnetic resonance 
imaging. This assessment was made by visual inspection. The 
nine positron emission tomographic slices were then grouped 
into three sets. Each set consisted of three positron emission 
tomographic slices, had a total thickness of 15 mm and 
anatomically included a single MRI slice. The resultant sets 
were subdivided into septal, anterior, lateral and inferior 
regions, as for MRI slices. Absolute myocardial blood flow was 
calculated for each region as previously reported (13). The 
ratio between maximal dobutamine blood flow and flow at 
baseline was also calculated. Of a total of 144 regions, 140 were 
suitable for comparison between positron emission tomogra- 
phy and MRI. To assess the relation betwecn myocardial blood 
flow and stenosis everity, only one flow value was calculated 
for each vascular territory (flow in the anteroseptal wall for the 
left anterior descending coronary after, in the lateral wall for 
the circumflex coronary artery and the inferior wall for the 
right coronary artery). 
Analysis of corona~ angiography. Standard coronary an- 
giography in multiple views was performed according to the 
standard Judkins technique for diagnostic purposes in the 
3-month period preceding the study. Angiograms were ana- 
lyzed visually by an experienced observer, who identified the 
stenotic segments. All stenotic segments were evaluated in the 
projection showing maximal severity, at end-diastole, by an 
automatic edge-contour detection system providing the per- 
cent diameter narrowing (Cardiovascular Angiographic Anal- 
ysis System, Pie Medical Equioment, Maastricht, the Nether- 
lands). The degree of stenosis was expressed as the percent 
reduction of the internal umen diameter in relation to the 
estimated iameter interpolated from the diameters at the 
proximal and distal boundaries of the stenosis. An obstruction 
was considered significant if it reduced the vessel lumen 
diameter ->50%. 
Statistical analysis. Results are expressed as mean value _+ 
SD. Analysis of variance for multiple comparisons, according 
to the Neuman-Keuls test, was used to check whether the 
systolic increase in blood pressure from baseline to 10/xg/kg 
per rain of dobutamine infusion was significant. Myocardial 
blood flow at baseline and during stress in each region as well 
as coronary reserve or blood flow within regions were com- 
pared by analysis of variance. Linear regression analysis was 
performed to detect correlations between flow (Y) and percent 
diameter stenosis (X). The fitted regression lines and the 
corresponding correlation coefficients are shown in Figure 3. A 
p value <0.05 was considered significant. 
Resul ts  
Hemodynamic variables. There were no significant differ- 
ences between systolic blood pressure, diastolic blood pressure 
and heart rate recorded uring positron emission tomographic 
and MRI studies, both at rest and during dobutamine infusion 
(Fig. 1). During both studies, there was a rapid increase in 
systolic blood pressure at 5 and 10 tzg/kg/min. Thereafter, a 
decrease was observed in three patients, whereas a slow and 
progressive increase was observed in the remaining patients. 
Diastolic blood pressure tended to decrease at low doses, and 
remained constant hereafter. Heart rate did not change 
significantly at 5 tzg/kg/min, although it increased progressively 
with increasing dose of dobutamine infusion (Fig. 1). 
Regional wall motion. Seven of 12 patients had regional 
wall motion abnormalities at baseline (Table 2). Individual 
responses to dobutamine are reported in Table 2. Five patients 
had negative dobutamine MRI scan results (i.e., they did not 
develop new or worsening wall motion abnormalities during 
stress). Of these five patients, only one received the maximal 
dose of dobutamine (i.e., 40 txg/kg per rain), whereas in four 
the test was stopped at a submaximal dose. Of the seven 
patients with positive MRI study results, diagnostic ST changes 
were documented in four. Four patients with positive results 
had chest pain: one had dyspnea nd mild chest pain; and one 
had isolated arterial hypotension. The maximal dose of dobut- 
amine was reached in only one patient with a positive response 
and no chest pain or diagnostic ST segment changes (Table 2). 
Of the 140 regions considered for comparison with positron 
emission tomographic data, 117 had normal and 23 abnormal 
wall motion at baseline (20 were hypokinetic and 3 akinetic). 
During stress, a new or a worsening wall motion abnormality 
occurred in 27 regions. Of these, 14 were normal and 13 
abnormal at rest. Ten regions with abnormal wall motion at 
rest did not show deterioration i  wall motion during dobut- 
amine administration. Of a total of 37 regions with abnormal 
wall motion during dobutamine infusion, 18 were hypokinetic 
and 19 akinetic or dyskinetic. Dobutamine-induced wall mo- 
tion abnormalities were always localized in a region subtended 
by a stenotic oronary artery. A representative example of a 
positive MRI study response is shown in Figure 2. 
Regional myocardial blood flow. At baseline, myocardial 
blood flow in the regions subtended by stenotic coronary 
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Figure 1. Changes in systolic (a, b) and dia- 
stolic (e, f) blood pressure and heart rate (c, d) 
during dobutamine infusion. Mean values for 
both magnetic resonance imaging (a, c, e) and 
positron emission tomography (b, d, f) are 
reported. 
arteries (i.e., those with ->50% diameter stenoses) was similar 
to that in regions upplied by either angiographically normal or 
minimally diseased coronary arteries (0.97 _+ 0.21 vs. 0.99 _+ 
0.32 ml/min per g, respectively, p > 0.28). Baseline flow was 
unrelated to stenosis everity (Fig. 3). During dobutamine, 
myocardial blood flow in regions upplied by angiographically 
normal or minimally diseased coronary arteries was 2.11 _+ 
0.82 ml/min per g, and that in regions subtended by stenotic 
coronary arteries was 1.56 + 0.76 ml/min per g (p < 0.01). 
Baseline and dobutamine flow in each vascular territory in all 
patients are shown in Table 3. Blood flow during dobutamine 
administration progressively decreased as the degree of steno- 
sis increased (Fig. 3). The ratio between dobutamine and rest 
blood flow was significantly ower in the regions ubtended by 
stenotic coronary arteries than that in regions supplied by 
either angiographically normal or minimally diseased coronary 
arteries (1.69 _+ 0.93 vs. 2.23 _+ 1.01 ml/min per g, respectively, 
p < 0.01). In the regions supplied by either normal or 
minimally diseased coronary arteries, myocardial blood flow 
during dobutamine administration was 1.40 _+ 0.39, 2.47 _ 0.58 
and 2.82 + 1.06 ml/min per g at 10, 20 and 40/xg/kg per min, 
respectively (p < 0.05 when the 10- and 20-~g/kg per rain 
Table 2. Dobutamine Stress Test 
Blood Pressure 
Max (ram Hg) HR (beats/min) Wall Motion (MRI) 
Dobutamine Max Max Max 
Pt Dose Dobutamine Dobutamine Dobutamine 
No. (tzg/kg per rain) Symptoms ECG Changes* Baseline Dose Baseline Dose Baseline Dose 
1 20 CP nd ST ~, leads V4-V 6 136/84 164/64 70 117 Normal - Normal 
2 20 CP ST ~, leads I-aVL-V4-V . 131/69 159/72 55 96 Hypo ant + Aki ant 
3 10 CP + SoB ST ~, leads I-aVL-V4-V~, 140/80 /74/76 94 110 Hypo ant-sept + Aki ant-sept 
4 25 Hypotension ST ~. leads V4-V ~ 150/83 142,'I 11} 58 105 Normal + Hypo ant-sept 
5 15 Hypotension 120/63 103/59 72 117 Normal - Normal 
6 20 CP + hypotension PVB 126/72 132/86 55 130 Hypo sept + Dys sept, Aki ant 
7 15 CP ST ,t, leads II-III-V3-V 6 150,,'1110 212,,'116 98 t17 Hypo inf + Aki inf-lat 
8 I0 CP ST J,, leads V~-V 5 150/11)tl 21)3/100 65 80 Normal - Normal 
9 40 PNT, leads V~-V6-I] 129/78 160/77 50 107 Hypo sept + Dys sept, Aki ant 
10 15 Bigeminy 127/84 163/81 49 61 Aki ant-sept - Aki ant-sept 
l l  40 132/79 184/90 66 120 Normal - Normal 
12 20 CP 139/72 152/75 63 110 Hypo ant-lat-inf + Dys lat, Aki inf 
*Recorded during dobutamine positron emission tomographic study. Aki akinesia; ant - anterior; CP - chest pain; Dys - dyskinesia; HR = heart rate; 
Hypo = hypokinesia; inf = inferior; lat = lateral; Max = maximal; MRI = magnetic resonance imaging; nd= nondiagnostic; PNT = pseudonormalization of egative 
T waves; Pt = patient; PVB - premature ventricular beats; sept = septal; SoB = shortness of breath; ST ~ = ST segment depression (->1 mm); + = positive 
dobutamine MRI test results; - negative dobataminc MRI test results. 
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Figure 2. Short-axis magnetic resonance images at baseline (left) and 
during dobutamine infusion (right) at end-diastole (ED, top) and 
end-systole (ES, bottom). At baseline, hypokinesia was present in the 
inferior wall of the left ventricle. During dobutamine infusion, akinesia 
of the inferior and lateral walls of the left ventricle occurred, which was 
accompanied by a reduction in thickening and by an enlargement of
the left ventricular cavity. The patient had occlusion of the fight 
coronary artery and 34% stenosis of the left circumflex coronary artery. 
values were compared; p < 0.05 when the 10- and 40-/~g/kg per 
min values were compared; p > 0.12 when the 20- and 
40-/~g/kg per rain values were compared). The corresponding 
baseline values were comparable (0.98 _+ 0.20, 1.01 _ 0.22 and 
1.03 +_ 0.15 ml/min per g, respectively, p > 0.26 and p > 0.3). 
The ratio between dobutamine and rest blood flow in regions 
supplied by either normal or minimally diseased coronary 
arteries was 1.45 _+ 0.35 ml/min per g at 10/~g/kg per min and 
2.47 _+ 1.19 ml/min per g at 20/sg/kg per min (p < 0.05) and 
tended to remain constant thereafter. At each dobutamine 
dose, the ratio was higher than that in regions subtended by 
stenotic oronary arteries (Fig. 4). 
Relation between regional wall motion and myocardial 
blood flow. At baseline, myocardial blood flow was similar in 
the regions with normal and abnormal wall motion (0.98 + 
0.25 vs. 0.96 + 0.35 ml/min per g, respectively, p > 0.21). 
Myocardial blood flow increased significantly during dobut- 
amine administration in the 113 regions that did not develop 
wall motion abnormalities (0.98 _+ 0.26 [baseline] vs. 1.98 _+ 
0.87 [dobutamine] ml/min per g, p < 0.001). By contrast, 
myocardial blood flow did not change significantly in the 27 
regions with stress-induced wall motion abnormalities (1.00 _+ 
0.28 [baseline] vs. 1.30 + 0.62 [dobutamine] ml/min per g, p > 
0.55). This was true even when the analysis was performed 
separately in regions with either normal or abnormal wall 
motion at rest (Fig. 5). Dobutamine myocardial blood flow in 
normal, hypokinetic and akinetic or dyskinetic regions is shown 
in Figure 6. The ratio of dobutamine torest flow was lower in 
regions with than in those without deterioration f wall motion 
during stress (1.41 _+ 0.72 vs. 2.11 _~ 1.02 ml/min per g, 
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Figure 3. Myocardial blood flow at baseline (top) and during dobut- 
amine infusion (bottom) in relation to percent stenosis of vessel 
diameter. Each vascular territory is reflected by only one flow value 
(flow in anteroseptal wall for the left anterior descending coronary 
artery, lateral wall for the circumflex coronary artery and inferior wall 
for the right coronary artery). There was no correlation between blood 
flow at baseline and degree of stenosis (top); flow during dobutamine 
decreased significantly as stenosis increased (bottom). 
respectively, p < 0.01). Within the regions without deteriora- 
tion of wall motion, there were no differences between those 
supplied by stenotic oronary arteries and those supplied by 
either normal or minimally diseased coronary arteries with 
regard to baseline myocardial blood flow (0.98 _ 0.35 vs. 
0.97 _+ 0.21 ml/min per g, respectively, p > 0.2), myocardial 
blood flow during dobutamine administration (1.72 _ 0.81 vs. 
2.11 _+ 0.87 mi/min per g, respectively, p > 0.1) and ratio of 
dobutamine to rest flow (1.88 _+ 1.01 vs. 2.23 - 1.02, ml/min 
per g, respectively, p > 0.15). An absolute decrease in myo- 
cardial blood flow below the value at rest was observed in seven 
segments that developed wall motion abnormalities during 
stress. 
Discuss ion  
To our knowledge, ours is the first study to evaluate in 
patients with coronary artery disease the effects of dobutamine 
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Table 3. Rest and Dobutamine Rate-Pressure Product and Myocardial Blood Flow Determined With Oxygen-15 Water 
Rate-Pressure Product Flow (ml/rnin per g) 
(beats/rain per mm Hg) LAD Cx RCA 
Pt No. R D D/R R D D/R R D D/R R D D/R 
1 6,9611 12,533 1.80 1.029 1.914 1.86 1.056 2.563 2.43 0.950 3.013 3,17 
2 7,425 17.172 2.31 0.908 1.931 2.13 1.200 2.852 2.36 0.824 3.257 3,95 
3 13,299 18.468 1.39 0.955 1.013 1.06 1.036 1.196 1.15 0.827 1.039 1,26 
4 8,379 17,325 2.07 1.024 1.875 1.83 0.954 2.224 2.33 0.862 2.069 2.40 
5 7,700 15,56 l 2.02 1.(193 2.344 2.14 0.560 2.278 4.07 0.567 1.456 2.57 
6 6,642 13,375 2.01 11.824 1.638 1.99 l. 100 2.553 2.30 0.746 1.619 2.17 
7 14,696 24,610 1,65 1.181 1.905 1.60 1.300 0.835 0.64 0.914 0.326 0.36 
8 10,269 20,739 2,02 0.907 1.323 1.46 0.962 1.100 1.14 0.792 1.360 1.72 
9 5,280 13,630 2,58 0.697 1.107 1.59 1.056 2,409 2.28 0.862 1.497 1.74 
10 4,935 7,176 1.45 0.791 1.080 1.37 1.164 1.498 1.29 0.832 1.293 1.55 
11 7,865 21,350 2.71 1.034 3.619 3.511 1.004 2.631 2.62 1.022 1.822 1.78 
12 8,960 17,248 1.92 0.947 2.133 2.25 1.445 2.217 1.53 1.892 1.488 0.79 
D = peak dobutamine dose: R = rest; other abbreviations as in Table 1. 
stress on both regional myocardial blood flow measured by 
positron emission tomography and left ventricular wall motion 
assessed with MRI using a fast magnetic resonance sequence 
in breath-hold. Results show that myocardial blood flow in the 
regions that developed wall motion abnormalities during do- 
butamine infusion did not increase, or even decreased, below 
the baseline value despite a marked increment in cardiac work 
load. In contrast, an increase in myocardial blood flow was 
observed during dobutamine infusion, both in the regions 
subtended by angiographically normal or minimally diseased 
coronary arteries and in those perfused by stenotic vessels but 
without mechanical evidence of ischemia. 
Comparison with previous studies. Assessment of left ven- 
tricular wall motion. Magnetic resonance imaging during do- 
butamine infusion was previously attempted in normal subjects 
and in patients with coronary artery disease (8,14,15). How- 
ever, the long acquisition time of the previous sequences 
precludes their use in the clinical setting (8,14-17). The 
sequence used in our study requires only 11 to 16 for acquiring 
one slice in cine film, making it particularly suitable and safe 
for the detection of transient ischemia. In addition, the short 
acquisition time allows a left ventricular wall motion evalua- 
tion at each dose of dobutamine, and the acquisition in 
breath-hold produces images unaffected by respiratory motion. 
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Figure 4. Dobutamine/rest flow ratio in regions sub- 
tended by angiographically normal or minimally dis- 
eased coronary arteries (open columns) and in those 
supplied by stenotic coronary arteries (hatched col- 
umns) at the maximal dobutamine infusion dose. Num- 
bers within the columns indicate the number of regions 
in each group. For each region only one value was 
considered because dobutamine flow was measured only 
at the highest dobutamine dose. In regions ubtended by 
angiographically normal or minimally diseased coronary 
arteries, a significant increase in dobutamine/rest flow 
ratio was observed from 10 to 20/@/kg per min; it did 
not increase significantly by increasing the dose to 
40 ~g/kg per min. In regions supplied by stenotic oro- 
nary arteries, the dobutamine/rest flow ratio was lower 
than that in regions subtended by normal or minimally 
diseased coronary arteries. Data shown are mean value 
(columns) _+ SE (vertical bars). 
dobutamine dose mcg/kg/min 
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Figure 5. Changes in myocardial g 
blood flow during dobutamine i fu- 
sion (open columns) in patients 
with negative and positive dobut- _~ 
amine stress test responses. Hatched 
columns = baseline. Data shown are 
mean value (columns) -+ SD (verti- 
cal bars). 
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The sensitivity of dobutamine-MRI for detection of coro- 
nary artery disease in our study is lower than the 91% 
previously reported (8,14). This is probably due to the high 
number of patients with single-vessel disease, for which the low 
sensitivity of all stress tests is well known (18). Also, any small 
sample size results in an unrepresentative absolute percent of 
sensitivity. However, the goal of any stress test in patients with 
coronary disease should not be to detect coronary stenosis 
itself, but the detection of stenoses capable of provoking 
ischemia. In our patients, a reduction in coronary flow during 
dobutamine infusion was found on average in the regions fed 
by stenotic vessels. However, only the areas with a more severe 
reduction in blood flow developed ischemia (positive dobut- 
amine MRI response). 
Assessment of myocardial blood flow. It is difficult to 
compare our data with previously published clinical studies 
because measurements of absolute myocardial blood flow 
Figure 6. Myocardial blood flow (mean [columns] = SD [vertical 
bars]) in normal (open columns), hypokinetic (hatched columns) and 
akinetic or dyskinetic regions (solid columns) at maximal dobutamine 
dose. 
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during high dose dobutamine infusion have not been reported 
in patients with coronary artery disease. In normal subjects, 
dobutamine up to 40 txg/kg per rain was found to increase 
myocardial blood flow from 0.77 to 2.25 ml/min per g, and both 
of these values are similar to our findings in regions upplied by 
normal coronary arteries (19). The lack of a significant in- 
crease in flow at dobutamine doses >20 ~xg/kg per min might 
have several explanations. A potential explanation could be an 
increase in oxygen extraction, as documented in reperfused 
myocardium in the canine model, or the progressive increase in 
heart rate, which reduces diastolic time with a consequent 
limitation in coronary flow (20). Other effects of high dose 
dobutamine infusion, such as changes in extravascular p es- 
sures, might explain these results. However, it is possible that 
the increase in blood flow at doses >20 p.g/kg per rain failed to 
reach statistical significance because of the small number of 
patients; that is, only two patients reached 40/xg/kg per min. In 
patients with coronary artery disease, low dose dobutamine 
(i.e., up to 10/xg/kg per min) was found to increase myocardial 
blood flow in regions with normal wall motion at baseline. In 
regions with abnormal wall motion at baseline, myocardial 
blood flow was found to increase significantly only in regions 
with blood flow metabolism ismatch, suggesting the presence 
of a still viable myocardium (21). In the present study, regions 
with abnormal motion at rest had a small increase in flow, also 
seen in the presence of a negative dobutamine MRI response. 
This finding could be explained by the presence of a mixture of 
viable and necrotic myocardium in regions with abnormal wall 
motion at rest. Another explanation might be a variable 
response of chronically dysfunctional myocardium toinotropic 
stimulation with dobutamine. A smaller increase in myocardial 
work in these regions might account for the absence of 
ischemia despite a lower flow increment han in normal 
regions. In the present study, maximal doses of dobutamine 
were not used in all cases; therefore, it cannot be excluded that 
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regions with abnormal motion at rest require a greater ino- 
tropic stimulation to respond. In our study, the values of 
myocardial blood flow at rest and during dobutamine infusion 
were lower than those reported by Sun et al. (21) for several 
reasons: 1) The doses of dobutamine used by Sun et al. were 
lower than ours; 2) the differing severity of wall motion 
abnormalities in the two patient groups (in our patients, 
abnormalities atrest, when present, consisted of hypokinesia in 
all cases except one); 3) blood flow with nitrogen-13 ammonia 
tends to be lower than that with the oxygen-15 water technique. 
Possible mechanisms responsible for dobutamine-induced 
myocardial ischemia. It is well known that dobutamine in- 
creases myocardial oxygen demand by increasing heart rate, 
inotropic state and wall stress (22). Generally, any increase in 
cardiac performance is paralleled by an increase in myocardial 
blood flow (23). However, the coronary vasodilator reserve in 
territories distal to coronary stenoses that may be partially 
exhausted under rest conditions may become completely ex- 
hausted during the lowest dobutamine doses. Experimental 
studies (24) in dogs have demonstrated that progressive vaso- 
dilation downstream from a coronary stenosis produces a 
decrease in coronary perfusion pressure. When perfusion 
pressure decreases below the "subendocardial opening pres- 
sure," selective subendocardial hypopeffusion occurs (trans- 
mural or vertical steal) (24). A vertical steal has been docu- 
mented by microspheres during dobutamine infusion in 
experimental coronary stenoses: Flow did not change from 
baseline in the subendocardium at 10/~g/kg per min, whereas 
it increased in the subepicardium (25,26). Similar results were 
found by Carlson et al. (27) at 15 t~g/kg per rain. In addition to 
vertical steal, horizontal steal may also occur when multivessel 
disease is present in a collateral-dependent region. After 
vasodilation, the decrease in pressure in the stenotic donor 
vessel leads to a decrease in collateral flow to the territory 
perfused by the more severely stenotic vessel. In the present 
study, both mechanisms might account for a decrease or no 
increase in flow in regions perfused by stenotic vessels. 
Limitations of the study. The major limitation of the study 
is the small number of patients tudied; therefore, our results 
need to be confirmed in a larger patient cohort. Myocardial 
blood flow in nonstenotic regions shows a large deviation from 
mean values, which could be due to the small number of 
observations at each dose and the different hemodynamic 
responses among patients. Whereas in some patients ystolic 
blood pressure increased progressively from 5/~g/kg per min to 
the maximal dose, in others it decreased. It is well known that 
blood pressure response to dobutamine is unpredictable be- 
cause of the balanced effects on smooth muscle tone and 
autonomic reflexes resulting from the increase in cardiac 
output. Thus, for similar doses of dobutamine, myocardial 
oxygen demand can substantially differ, which may explain the 
differences in blood flow between patients at the same dose. 
The effect of dobutamine can also be affected by the therapy. 
Patients topped taking beta-blockers 4 days before each study, 
but the effect of these drugs could persist after 4 days in some 
patients, whereas in others a rebound effect could occur. 
In the present study, blood flow was measured only at rest 
and at maximal dobutamine dose. Therefore, it was not 
possible to measure flow at incremental dobutamine doses in 
the same region in each patient. However, this relation was 
evaluated using the pooled data from the different patients. 
The MRI sequence used has the advantage of a short 
acquisition time and the disadvantage of a relatively low spatial 
resolution compared with other sequences, making the quan- 
titative analysis of wall motion dill]cult. However, the spatial 
resolution achieved ( -3  ram) still compares favorably with 
other conventional imaging techniques. The wall motion of an 
ischemic area is visualized as either abnormal systolic thicken- 
ing or as a contraction heterogeneity, and the latter needs 
visual analysis by cine film to be detected. 
Conclusions. Compared with baseline values, myocardial 
blood flow during dobutamine infusion increased significantly 
in regions subtended by either angiographically normal or 
minimally diseased coronary arteries. In the regions fed by 
stenotic vessels, a lower increase in flow was observed; how- 
ever, only the regions with lowest blood flows during dobut- 
amine infusion developed ischemia. This result implies that 
imaging techniques, such as dobutamine-thall ium and 
dobutamine-echocardiography, in widespread use in the clin- 
ical setting, provide different information. The former, which 
detects relative flow differences, is more sensitive for the 
detection of coronary artery stenoses, whereas the latter, which 
requires mechanical dysfunction as the diagnostic end point, is 
more suitable for identification of coronary artery stenoses 
capable of provoking ischemia. 
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